HB 3717 Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy

Texas 89th Legislature Regular Session